Atea Pharmaceuticals (AVIR) Short-term Investments (2022 - 2026)
Atea Pharmaceuticals' Short-term Investments was $142.92 million in Q2 2026, down 51.1% from $291.99 million a year earlier and down 19.1% from the prior quarter.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) Short-term Investments (2022 - 2026) Analysis & Trends
At the end of FY2025, Short-term Investments at Atea Pharmaceuticals came in at $206.12 million, down 47.2% from FY2024.
- Short-term Investments has now declined for three consecutive years, with a three-year compound annual growth rate of -23.4% (FY2022 to FY2025).
- In earlier years, Short-term Investments was $390.03 million in FY2024 (-10.2%), $434.28 million in FY2023 (-5.2%) and $458.25 million in FY2022.
- The Q2 2026 figure marks the lowest quarterly Short-term Investments in data going back to Q3 2022.
- Compared with a year earlier, Short-term Investments has declined for four straight quarters, with an average decline of 26.0% over the last eight quarters.
- The best year-over-year quarter for Short-term Investments over five years was Q2 2025 (growth of 12.8%); the worst was Q2 2026 (a decline of 51.1%).
- Per Business Quant data, AVIR's Short-term Investments in the three quarters before Q2 2026 was $176.69 million (Q1 2026), $206.12 million (Q4 2025) and $251.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Atea Pharmaceuticals | 324.83 Mn | -781.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 142.92 Mn |
| Mar 31, 2026 | 176.69 Mn |
| Dec 31, 2025 | 206.12 Mn |
| Sep 30, 2025 | 251.97 Mn |
| Jun 30, 2025 | 291.99 Mn |
| Mar 31, 2025 | 306.04 Mn |
| Dec 31, 2024 | 390.03 Mn |
| Sep 30, 2024 | 384.35 Mn |
| Jun 30, 2024 | 258.82 Mn |
| Mar 31, 2024 | 380.58 Mn |
| Dec 31, 2023 | 434.28 Mn |
| Sep 30, 2023 | 457.24 Mn |
| Jun 30, 2023 | 394.36 Mn |
| Mar 31, 2023 | 437.23 Mn |
| Dec 31, 2022 | 458.25 Mn |
| Sep 30, 2022 | 488.57 Mn |
API Access
Atea Pharmaceuticals Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=AVIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "AVIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=AVIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();